These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 22312232)
1. Ensuring safe access to medication for palliative care while preventing prescription drug abuse: innovations for American inner cities, rural areas, and communities overwhelmed by addiction. Francoeur RB Risk Manag Healthc Policy; 2011; 4():97-105. PubMed ID: 22312232 [TBL] [Abstract][Full Text] [Related]
2. Tamper-resistant opioid formulations in the treatment of acute pain. Passik SD Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323 [TBL] [Abstract][Full Text] [Related]
3. The Role of Pharmacists in Safe Opioid Dispensing. Gregory T; Gregory L J Pharm Pract; 2020 Dec; 33(6):856-862. PubMed ID: 31256700 [TBL] [Abstract][Full Text] [Related]
4. Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs. Hahn KL Am Health Drug Benefits; 2011 Mar; 4(2):107-14. PubMed ID: 25126342 [TBL] [Abstract][Full Text] [Related]
5. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350 [TBL] [Abstract][Full Text] [Related]
6. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Manchikanti L Pain Physician; 2006 Oct; 9(4):287-321. PubMed ID: 17066115 [TBL] [Abstract][Full Text] [Related]
8. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland. Matheson C; Bond CM; Hickey F Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708 [TBL] [Abstract][Full Text] [Related]
10. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment. Norwood CW; Wright ER Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489 [TBL] [Abstract][Full Text] [Related]
11. An opioid dispensing and misuse prevention algorithm for community pharmacy practice. Rickles NM; Huang AL; Gunther MB; Chan WJ Res Social Adm Pharm; 2019 Aug; 15(8):959-965. PubMed ID: 29525483 [TBL] [Abstract][Full Text] [Related]
12. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. Cobaugh DJ; Gainor C; Gaston CL; Kwong TC; Magnani B; McPherson ML; Painter JT; Krenzelok EP Am J Health Syst Pharm; 2014 Sep; 71(18):1539-54. PubMed ID: 25174015 [TBL] [Abstract][Full Text] [Related]
13. Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use? Lourenço LM; Matthews M; Jamison RN Expert Opin Drug Deliv; 2013 Feb; 10(2):229-40. PubMed ID: 23252692 [TBL] [Abstract][Full Text] [Related]
15. Treating Addiction to Prescription Opioids. Li X; Kosten T S D Med; 2016 Spec; No():64-67. PubMed ID: 28817853 [TBL] [Abstract][Full Text] [Related]
16. Methadone related deaths compared to all prescription related deaths. Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639 [TBL] [Abstract][Full Text] [Related]
17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
18. Patterns of prescription medication diversion among drug dealers. Rigg KK; Kurtz SP; Surratt HL Drugs (Abingdon Engl); 2012; 19(2):144-155. PubMed ID: 22665955 [TBL] [Abstract][Full Text] [Related]
19. Community pharmacies as access points for addiction treatment. Look KA; Kile M; Morgan K; Roberts A Res Social Adm Pharm; 2019 Apr; 15(4):404-409. PubMed ID: 29909934 [TBL] [Abstract][Full Text] [Related]